| Revenue | NOK 0 | — |
| EBITDA | NOK -6K | +45% |
| Net profit | NOK -6K | +85% |
| Total assets | NOK 966K | +7% |
| Equity | NOK 806K | -1% |
| Employees | 0 | — |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 42 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −9 | −6 | 36 | −11 | −6 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −9 | −6 | 36 | −11 | −6 |
| Net financials | 0 | 598 | −6 | −30 | 0 |
| Profit before tax | −9 | 592 | 30 | −41 | −6 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −9 | 592 | 30 | −41 | −6 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 464 | 1 558 | 943 | 902 | 966 |
| Equity | 232 | 824 | 854 | 812 | 806 |
| Long-term debt | 0 | 734 | 90 | 90 | 160 |
| Short-term debt | 233 | 0 | 0 | 0 | 0 |
| Total debt | 233 | 734 | 90 | 90 | 160 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
DA Chief Executive Officer | Chief Executive Officer | 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2017 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50% | 50% | 2022 |
| Person | Role here | Other companies |
|---|---|---|
| Daniel Andreas Stockhausen Hektoen | Chief Executive Officer | 0 companies |
| Cecilie Yggeseth Hektoen | Board of Directors | 0 companies |